These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17138752)

  • 1. The role of modern biology and medicine in drug development in academia and industry.
    Blake CA; Barker KL; Sobel BE
    Exp Biol Med (Maywood); 2006 Dec; 231(11):1680-1. PubMed ID: 17138752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective partnering of academic and physician scientists with the pharmaceutical drug development industry.
    Kennedy SP; Bormann BJ
    Exp Biol Med (Maywood); 2006 Dec; 231(11):1690-4. PubMed ID: 17138755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational research in academia and industry.
    Clackson T
    Exp Biol Med (Maywood); 2006 Dec; 231(11):1685-9. PubMed ID: 17138754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The path from bench to bedside: considerations before starting the journey.
    Freeman MW; Dervan AP
    J Investig Med; 2011 Jun; 59(5):746-51. PubMed ID: 21441830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing environment of graduate and postdoctoral training in drug metabolism: viewpoints from academia, industry, and government.
    Stevens JC; Dean DC; Preusch PC; Correia MA
    Drug Metab Dispos; 2003 Apr; 31(4):360-6. PubMed ID: 12642460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Alzheimer disease drug discovery and development in academia.
    Van Eldik LJ; Koppal T; Watterson DM
    Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S18-28. PubMed ID: 12070358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At issue: A model for academic/industry collaboration.
    Carpenter WT; Koenig JI; Bilbe G; Bischoff S
    Schizophr Bull; 2004; 30(4):997-1004. PubMed ID: 15954203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
    Mooney KG
    Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry's challenge to academia: changing the bench to bedside paradigm.
    Fluckiger SL
    Exp Biol Med (Maywood); 2006 Jul; 231(7):1257-61. PubMed ID: 16816131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 13. Helping science and drug development to succeed through pharma-academia partnerships: Yale Healthcare Conference 2013.
    Yang DX; Kim YA
    Yale J Biol Med; 2013 Sep; 86(3):429-32. PubMed ID: 24058318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 15. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Academic-Pharma drug discovery alliances: seeking ways to eliminate the valley of death.
    Hammonds T
    Future Med Chem; 2015; 7(14):1891-9. PubMed ID: 26393391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho Chi lecture. Pharmaceutical sciences in the next millennium.
    Triggle DJ
    Ann Pharmacother; 1999 Feb; 33(2):241-6. PubMed ID: 10084422
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.